Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 34

1.

p38 MAPK controls prothrombin expression by regulated RNA 3' end processing.

Danckwardt S, Gantzert AS, Macher-Goeppinger S, Probst HC, Gentzel M, Wilm M, Gröne HJ, Schirmacher P, Hentze MW, Kulozik AE.

Mol Cell. 2011 Feb 4;41(3):298-310. doi: 10.1016/j.molcel.2010.12.032.

2.
4.
5.

Calcium-induced matrix metalloproteinase 9 gene expression is differentially regulated by ERK1/2 and p38 MAPK in oral keratinocytes and oral squamous cell carcinoma.

Mukhopadhyay S, Munshi HG, Kambhampati S, Sassano A, Platanias LC, Stack MS.

J Biol Chem. 2004 Aug 6;279(32):33139-46. Epub 2004 Jun 4.

7.

The involvement of AU-rich element-binding proteins in p38 mitogen-activated protein kinase pathway-mediated mRNA stabilisation.

Dean JL, Sully G, Clark AR, Saklatvala J.

Cell Signal. 2004 Oct;16(10):1113-21. Review.

PMID:
15240006
9.

P38 MAPK mediates COX-2 gene expression by corticosterone in cardiomyocytes.

Sun H, Xu B, Inoue H, Chen QM.

Cell Signal. 2008 Nov;20(11):1952-9. doi: 10.1016/j.cellsig.2008.07.003. Epub 2008 Jul 6.

PMID:
18657608
10.

Contribution of MKP-1 regulation of p38 to endotoxin tolerance.

Nimah M, Zhao B, Denenberg AG, Bueno O, Molkentin J, Wong HR, Shanley TP.

Shock. 2005 Jan;23(1):80-7.

PMID:
15614136
11.

Statins activate peroxisome proliferator-activated receptor gamma through extracellular signal-regulated kinase 1/2 and p38 mitogen-activated protein kinase-dependent cyclooxygenase-2 expression in macrophages.

Yano M, Matsumura T, Senokuchi T, Ishii N, Murata Y, Taketa K, Motoshima H, Taguchi T, Sonoda K, Kukidome D, Takuwa Y, Kawada T, Brownlee M, Nishikawa T, Araki E.

Circ Res. 2007 May 25;100(10):1442-51. Epub 2007 Apr 26.

12.

Splicing factors stimulate polyadenylation via USEs at non-canonical 3' end formation signals.

Danckwardt S, Kaufmann I, Gentzel M, Foerstner KU, Gantzert AS, Gehring NH, Neu-Yilik G, Bork P, Keller W, Wilm M, Hentze MW, Kulozik AE.

EMBO J. 2007 Jun 6;26(11):2658-69. Epub 2007 Apr 26.

13.

Cdc42Hs, but not Rac1, inhibits serum-stimulated cell cycle progression at G1/S through a mechanism requiring p38/RK.

Molnár A, Theodoras AM, Zon LI, Kyriakis JM.

J Biol Chem. 1997 May 16;272(20):13229-35.

14.

c-Jun N-terminal kinase and p38 mitogen-activated protein kinase mediate double-strand RNA-induced inducible nitric oxide synthase expression in microglial cells.

Kong PJ, Lee HJ, Lee SH, Kim SY, Lee SN, Chun WJ, Kim SS.

Neurosci Lett. 2008 Mar 15;433(3):215-8. doi: 10.1016/j.neulet.2007.10.052. Epub 2008 Jan 16.

PMID:
18258363
15.
16.

Protoapigenone, a novel flavonoid, induces apoptosis in human prostate cancer cells through activation of p38 mitogen-activated protein kinase and c-Jun NH2-terminal kinase 1/2.

Chang HL, Wu YC, Su JH, Yeh YT, Yuan SS.

J Pharmacol Exp Ther. 2008 Jun;325(3):841-9. doi: 10.1124/jpet.107.135442. Epub 2008 Mar 12.

18.

Involvement of the p38 MAPK pathway in IL-13-induced mucous cell metaplasia in mouse tracheal epithelial cells.

Fujisawa T, Ide K, Holtzman MJ, Suda T, Suzuki K, Kuroishi S, Chida K, Nakamura H.

Respirology. 2008 Mar;13(2):191-202. doi: 10.1111/j.1440-1843.2008.01237.x.

PMID:
18339016
19.

Cyclin D1 expression is regulated positively by the p42/p44MAPK and negatively by the p38/HOGMAPK pathway.

Lavoie JN, L'Allemain G, Brunet A, Müller R, Pouysségur J.

J Biol Chem. 1996 Aug 23;271(34):20608-16.

20.

Cyclooxygenase-2 expression induced by photofrin photodynamic therapy involves the p38 MAPK pathway.

Luna M, Wong S, Ferrario A, Gomer CJ.

Photochem Photobiol. 2008 Mar-Apr;84(2):509-14. doi: 10.1111/j.1751-1097.2007.00299.x. Epub 2008 Feb 11.

PMID:
18282182

Supplemental Content

Support Center